Gallo KA - Search Results

1

The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis.

Occhiuto CJ, Moerland JA, Leal AS, Gallo KA, Liby KT. Occhiuto CJ, et al. Among authors: gallo ka. Mol Cells. 2023 Mar 31;46(3):176-186. doi: 10.14348/molcells.2023.2191. Epub 2023 Mar 22. Mol Cells. 2023. PMID: 36994476 Free PMC article. Review.

2

Exploring structural effects in a new class of NRF2 inhibitors.

Hou Z, Lockwood L, Zhang D, Occhiuto CJ, Mo L, Aldrich KE, Stoub HE, Gallo KA, Liby KT, Odom AL. Hou Z, et al. Among authors: gallo ka. RSC Med Chem. 2022 Nov 16;14(1):74-84. doi: 10.1039/d2md00211f. eCollection 2023 Jan 25. RSC Med Chem. 2022. PMID: 36760735 Free PMC article.

3

Targeting mixed lineage kinases in ER-positive breast cancer cells leads to G2/M cell cycle arrest and apoptosis.

Wang L, Gallo KA, Conrad SE. Wang L, et al. Among authors: gallo ka. Oncotarget. 2013 Aug;4(8):1158-71. doi: 10.18632/oncotarget.1093. Oncotarget. 2013. PMID: 23902710 Free PMC article.

4

Therapeutic potential of targeting mixed lineage kinases in cancer and inflammation.

Gallo KA, Ellsworth E, Stoub H, Conrad SE. Gallo KA, et al. Pharmacol Ther. 2020 Mar;207:107457. doi: 10.1016/j.pharmthera.2019.107457. Epub 2019 Dec 18. Pharmacol Ther. 2020. PMID: 31863814 Review.

5

Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in NRAS-Mutant Melanoma Cell Lines.

Appleton KM, Palsuledesai CC, Misek SA, Blake M, Zagorski J, Gallo KA, Dexheimer TS, Neubig RR. Appleton KM, et al. Among authors: gallo ka. Cancers (Basel). 2021 Apr 22;13(9):2012. doi: 10.3390/cancers13092012. Cancers (Basel). 2021. PMID: 33921974 Free PMC article.

6

Inhibition of the Rho/MRTF pathway improves the response of BRAF-resistant melanoma to PD1/PDL1 blockade.

Foda BM, Misek SA, Gallo KA, Neubig RR. Foda BM, et al. Among authors: gallo ka. Int J Cancer. 2024 Oct 1;155(7):1303-1315. doi: 10.1002/ijc.35056. Epub 2024 Jun 19. Int J Cancer. 2024. PMID: 38898604

7

MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells.

Rattanasinchai C, Llewellyn BJ, Conrad SE, Gallo KA. Rattanasinchai C, et al. Among authors: gallo ka. Oncogenesis. 2017 Jun 12;6(6):e345. doi: 10.1038/oncsis.2017.44. Oncogenesis. 2017. PMID: 28604765 Free PMC article.

8

BRAF Inhibitor Resistance Confers Increased Sensitivity to Mitotic Inhibitors.

Misek SA, Foda BM, Dexheimer TS, Akram M, Conrad SE, Schmidt JC, Neubig RR, Gallo KA. Misek SA, et al. Among authors: gallo ka. Front Oncol. 2022 Apr 4;12:766794. doi: 10.3389/fonc.2022.766794. eCollection 2022. Front Oncol. 2022. PMID: 35444937 Free PMC article.

9

Endothelin-1 enriched tumor phenotype predicts breast cancer recurrence.

Tamkus D, Sikorskii A, Gallo KA, Wiese DA, Leece C, Madhukar BV, Chivu SC, Chitneni S, Dimitrov NV. Tamkus D, et al. Among authors: gallo ka. ISRN Oncol. 2013 Jun 12;2013:385398. doi: 10.1155/2013/385398. Print 2013. ISRN Oncol. 2013. PMID: 23844294 Free PMC article.

10

Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme.

Bernal Rubio YL, González-Reymúndez A, Wu KH, Griguer CE, Steibel JP, de Los Campos G, Doseff A, Gallo K, Vazquez AI. Bernal Rubio YL, et al. G3 (Bethesda). 2018 Nov 6;8(11):3627-3636. doi: 10.1534/g3.118.200391. G3 (Bethesda). 2018. PMID: 30228192 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters